Indeed, a significant (p < 0.001) inhibition of tumor growth was observed: tumor size at the end of the 11-day evaluation period reached 502 mm3 in the control group and 186 mm3 in the IL-2 group. This evidence concerns the gene IL2 and neoplasm.